CHIP(-/-)-Mouse Liver: Adiponectin-AMPK-FOXO-Activation Overrides CYP2E1-Elicited JNK1-Activation, Delaying Onset of NASH: Therapeutic Implications.
about
The Ubiquitin Ligase CHIP Integrates Proteostasis and Aging by Regulation of Insulin Receptor TurnoverAdipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions.Hepatic cytochromes P450: structural degrons and barcodes, posttranslational modifications and cellular adapters in the ERAD-endgame.Enhancement of Adiponectin Ameliorates Nonalcoholic Fatty Liver Disease via Inhibition of FoxO1 in Type I Diabetic Rats
P2860
CHIP(-/-)-Mouse Liver: Adiponectin-AMPK-FOXO-Activation Overrides CYP2E1-Elicited JNK1-Activation, Delaying Onset of NASH: Therapeutic Implications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CHIP(-/-)-Mouse Liver: Adipone ...... ASH: Therapeutic Implications.
@en
CHIP(-/-)-Mouse Liver: Adipone ...... ASH: Therapeutic Implications.
@nl
type
label
CHIP(-/-)-Mouse Liver: Adipone ...... ASH: Therapeutic Implications.
@en
CHIP(-/-)-Mouse Liver: Adipone ...... ASH: Therapeutic Implications.
@nl
prefLabel
CHIP(-/-)-Mouse Liver: Adipone ...... ASH: Therapeutic Implications.
@en
CHIP(-/-)-Mouse Liver: Adipone ...... ASH: Therapeutic Implications.
@nl
P2093
P2860
P356
P1433
P1476
CHIP(-/-)-Mouse Liver: Adipone ...... ASH: Therapeutic Implications.
@en
P2093
Cam Patterson
James P Grenert
Maria Almira Correia
Sung-Mi Kim
P2860
P2888
P356
10.1038/SREP29423
P407
P577
2016-07-12T00:00:00Z